MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Baseline multimodal information predicts future motor impairment in premanifest Huntington’s disease

    E. Castro, P. Polosecki, I. Rish, G. Cecchi (Yorktown Heights, NY, USA)

    Objective: To evaluate the prognostic accuracy of structural magnetic resonance imaging and genetic-based measures in premanifest Huntington’s disease for estimating future motor impairment. Background: Despite…
  • 2017 International Congress

    Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease

    T. Capato, M. Haddad, E. Barbosa, M.E. Piemonte (Sao Paulo, Brazil)

    Objective: Identify the Evidence based Physicaltherapy available for HD and provide recommendations to physicians   Background: In Huntington’s Disease (HD) Chorea is usually presented in any phase…
  • 2017 International Congress

    Factors Influencing Completion of Predictive Testing for Huntington’s Disease (HD)

    M. Patel, V. Sung (Birmingham, AL, USA)

    Objective: To determine if the new simplified testing protocol led to an increase in completion rate of predictive testing for HD, and to study some…
  • 2017 International Congress

    Sensory modulation of postural control in Huntington’s disease

    F. Porciuncula, K. Marder, P. Wasserman, A. Rao (New York, NY, USA)

    Objective: To characterize sensory modulation of postural control in Huntington's disease (HD); and to identify postural metrics that are sensitive in the prodromal stage of…
  • 2017 International Congress

    Admission Diagnoses and Eventual Discharge Dispositions for Hospitalized Huntington’s Disease Patients: Results of a Nationwide Survey

    S. Gupta, F. Benesh, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the causes of acute illness and its consequences for subsequent inpatient care in patients with Huntington’s Disease (HD). Background: HD is…
  • 2017 International Congress

    Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes

    F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the relationship between Huntington’s Disease and depression. Background: Huntington’s Disease (HD) is an uncommon genetic neurodegenerative disorder in the United States…
  • 2017 International Congress

    Social hindrances for diagnosing Huntington’s disease

    A. Alboudi, P. Sarathchandran, A.B. Almadani (Dubai, United Arab Emirates)

    Objective: The need to differentiate the malingering from real complains Careful history can give a strong clue for the diagnosis Criminals can have diseases also…
  • 2017 International Congress

    Myoclonus in adult onset Huntington’s disease

    S. McAllister, S. Shipley, J. Shah, R. Fekete (New York, NY, USA)

    Objective: We present a case report of adult onset Huntington's disease (HD) with myoclonus as the main clinical feature. Background: Myoclonus is seldom reported as…
  • 2017 International Congress

    Evaluation of serum sestrin protein in Parkinson’s disease: a plausible diagnostic marker

    S. Dey, N. Rai, A. Singh, S. Shekhar, A. Dey (New Delhi, India)

    Objective: In this study, we evaluated the concentrations of sesn1 and sesn2 in the serum of 50 PD patients and 60 elderly controls. Aging is…
  • 2017 International Congress

    Parkinson ‘ s disease and Peripheral Nervous System  : Wax and Waning Non-motor offs and Levodopa-use Topics

    s.g. echebarria mendieta (-, Spain)

    Objective: To relate the non-motor offs theory , sensory signs and levodopa use with neurophysiiology  terms in PD Background: Peripheral Nervous System disease concept in…
  • « Previous Page
  • 1
  • …
  • 1241
  • 1242
  • 1243
  • 1244
  • 1245
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley